APA (7th ed.) Citation

Andreozzi, F., Dragani, M., Quivoron, C., Le Bras, F., Assi, T., Danu, A., . . . Michot, J. (2023). Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study. Cancers, 15(5), 1508. https://doi.org/10.3390/cancers15051508

Chicago Style (17th ed.) Citation

Andreozzi, Fabio, et al. "Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study." Cancers 15, no. 5 (2023): 1508. https://doi.org/10.3390/cancers15051508.

MLA (9th ed.) Citation

Andreozzi, Fabio, et al. "Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study." Cancers, vol. 15, no. 5, 2023, p. 1508, https://doi.org/10.3390/cancers15051508.